{
  "nctId": "NCT03682367",
  "briefTitle": "Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery",
  "officialTitle": "Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery: A Randomized Controlled Trial",
  "protocolDocument": {
    "nctId": "NCT03682367",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2019-11-26",
    "uploadDate": "2021-06-03T18:08",
    "size": 685830,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03682367/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE3"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "TRIPLE",
  "enrollmentInfo": {
    "enrollmentCount": 8,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2018-12-01",
    "completionDate": "2020-04-06",
    "primaryCompletionDate": "2020-04-01",
    "firstSubmitDate": "2018-09-21",
    "firstPostDate": "2018-09-24"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients undergoing major head and neck surgery with concomitant free flap reconstruction surgery at UCDMC (oncology and non-oncologic): There will be two groups. Group 1 will include reconstruction with fibula free flap only. Group 2 will include any other free flap reconstruction, including scapular free flap, radial forearm free flap, anterolateral thigh free flap, anteromedial thigh free flap, and latissimus dorsi free flap.\n* Patients naÃ¯ve to gabapentin\n* Adult patients \\>18 years of age and able to consent\n\nExclusion Criteria:\n\n* Patients who are already taking scheduled gabapentin\n* Patients allergic to gabapentin\n* Chronic opioid use not from active head and neck cancer\n* Illicit drug use (per report)\n* Patients with known renal compromise, such that Creatinine clearance is \\< 30\n* Patient with known hepatic insufficiency or cirrhosis\n* Adults unable to consent\n* Individuals less than 18 years old\n* Pregnant women\n* Prisoners",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Average Morphine Equivalent Units",
        "description": "Determine the difference in average morphine equivalent units between experimental and control group.",
        "timeFrame": "Perioperative."
      },
      {
        "measure": "Average Morphine Equivalent Units",
        "description": "Determine the difference in average morphine equivalent units between experimental and control group.",
        "timeFrame": "1 week post-operation."
      },
      {
        "measure": "Average Morphine Equivalent Units",
        "description": "Determine the difference in average morphine equivalent units between experimental and control group.",
        "timeFrame": "30 days post-operation."
      }
    ],
    "secondary": [
      {
        "measure": "Pain Score (10 Point VAS)",
        "description": "Determine average change of inpatient Pain Score Visual Analog Scale (VAS) on a standardized 1 (no pain) to 10 (highest level of pain) scale between experimental and control groups.",
        "timeFrame": "Perioperative, 1 week post-operation, 1 week post-discharge, and 30 days post-operation."
      },
      {
        "measure": "Post-operative Complications",
        "description": "Incidence of postoperative complications between experimental and control group.",
        "timeFrame": "30 days post-operation."
      },
      {
        "measure": "Narcotics-related Complications",
        "description": "Incidence of narcotics-related complications between experimental and control group.",
        "timeFrame": "30 days post-operation."
      },
      {
        "measure": "Inpatient Length of Stay",
        "description": "Determine the difference of average inpatient length of stay between experimental and control group.",
        "timeFrame": "1 week post-operation."
      },
      {
        "measure": "Inpatient Cost",
        "description": "Determine the difference of average inpatient cost between experimental and control group.",
        "timeFrame": "1 week post-operation."
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 3,
      "secondaryCount": 5,
      "otherCount": 0,
      "totalCount": 8
    },
    "studyDesign": {
      "phases": [
        "PHASE3"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 84,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:31:00.803Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}